greeksoup/ stock research

Ingevity (NGVT) FY2020 results: revenue $1.2 billion, down 5.9% on the year

Ingevity Corp. (NGVT) reported revenue of $1.2 billion for fiscal 2020, the year ended 31 December 2020, down 5.9% on the year before. Net income was $181 million, down 1.3%, and diluted earnings per share $4.37. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2021.

Revenue
$1.2 billion
-5.9% on the year
FY2014FY2020
Operating margin
32.7%
30.7% a year earlier
FY2014FY2020
Net income
$181 million
-1.3% on the year
FY2014FY2020
Diluted EPS
$4.37
+0.5% on the year
FY2014FY2020

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2020FY2019FY2018On the yearLast 8 years
Revenue1,2161,2931,134-5.9%
Cost of revenue751811717-7.4%
Gross profit466482417-3.4%
Gross margin38.3%37.3%36.8%
Research and development22.619.721.5+14.7%
Selling, general and administrative149163132-8.4%
Operating income398397320+0.3%
Operating margin32.7%30.7%28.3%
Interest expense47.154.633.2-13.7%
Pre-tax income235228222+3.2%
Income tax53.744.240.0+21.5%
Effective tax rate22.8%19.4%18.0%
Net income181184169-1.3%
Net margin14.9%14.2%14.9%
Diluted EPS$4.37$4.35$3.97+0.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2020FY2019FY2018On the yearLast 8 years
Operating cash flow352276252+27.8%
Capital expenditure82.111593.9-28.5%
Free cash flow270161158+68.0%
Free cash flow margin22.2%12.4%13.9%
Cash from investing-111-658-414
Cash from financing-50.2369154
Depreciation and amortisation10085.057.0+17.9%
Share-based compensation8.412.312.5-31.7%
Buybacks88.06.447.4+1,275.0%
Diluted shares, weighted42m42m43m-1.5%
Shares outstanding at period end41m42m42m-3.1%

Balance sheet

$ millionFY2020FY2019FY2018On the yearLast 8 years
Shareholders' equity642531339+21.0%
Non-controlling interestn/an/a0.0
Debt1,3061,258759+3.9%
Operating lease liabilities34.736.70.0-5.4%
Finance lease liabilities10280.0n/a+28.0%
Other liabilities249236218+5.2%
Total liabilities and equity2,3342,1421,315+9.0%
Fixed assets704665524+5.9%
Goodwill445436131+2.0%
Intangible assets373396126-5.8%
Investments0.0n/an/a
Cash and equivalents25856.577.5+356.1%
Receivables148150119-1.3%
Inventory189212191-11.1%
Other assets218225147-3.5%
Total assets2,3342,1421,315+9.0%

10-K for the year ended 31 December 2020, filed 19 February 2021: the filing.